Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT04323189
PHASE4

Effects of Sitagliptin in Individuals With Genetically Decreased DPP4

Sponsor: University of Pennsylvania

View on ClinicalTrials.gov

Summary

This is a pilot clinical trial to test the hypothesis that during sitagliptin (DPP4 inhibitor), individuals heterozygous for DPP4 loss of function variants will have a reduction in DPP4 activity and antigen, lower glucose after a mixed meal, and higher levels of intact DPP4 substrates compared to during placebo and compared to matched controls.

Key Details

Gender

All

Age Range

18 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

20

Start Date

2020-08-26

Completion Date

2026-02-28

Last Updated

2026-01-16

Healthy Volunteers

No

Interventions

DRUG

Sitagliptin 100mg

Sitagliptin will be administered daily for 7 days, with a study day on day 7.

DRUG

Placebo Oral Tablet

Placebo will be administered daily for 7 days, with a study day on day 7.

Locations (1)

University of Pennsylvania

Philadelphia, Pennsylvania, United States